For a scientific overview of the microbiome, the difference between GLP-1 agonist drugs and microbial approaches to regulating GLP-1, and the role GLP-1 plays in helping to maintain a healthy weight, please refer to the white paper: Harnessing GLP-1 in the digestive tract for better metabolic health
A 2025 meta-analysis in Scientific Reports found that GLP-1 receptor agonists reduced body weight, BMI, and insulin resistance in women with PCOS, although nausea, vomiting, and dizziness were more common
This nausea can sometimes be significant
Singh acknowledges the Department of Science and Technology (DST), Government of India, for financial support provided under the Women Scientist Scheme (DST/WOS-B)
A melatonin preparation with a pulsatile liberation pattern: a new form of melatonin [PMID: 10085470] Laboratory literature summary: A melatonin preparation with a pulsatile liberation pattern: a new form of melatonin in replacement research protocol
Proc Natl Acad Sci USA 2000